Introduction
The inflammatory response in allergic asthma has largely been characterized by a dysregulated adaptive immune response involving the differentiation of Th2 cells that produce interleukin (IL)-4, IL-5, and IL-13 resulting in IgE production, eosinophil infiltration and mucus production in the lungs [1] . Though much has been learned about pathogenic adaptive Th2 cell responses over the past few decades, recent studies have demonstrated that innate type 2 responses also contribute to tissue eosino-philia and mucus production independent of the presence of adaptive immune cells [2] [3] [4] . We recently reported that a single administration of the fungal allergen extract Alternaria alternata given to unsensitized mice results in airway eosinophilia and increased IL-5 levels and is present in RAG2-deficient mice that lack B and T cells [5, 6] . Further, we have shown that IL-5-producing innate lymphoid cells (ILC2) are rapidly activated after Alternaria extract challenge and contribute to lung eosinophilia [6] . This suggests that the adaptive Th2 paradigm may not completely explain type 2 responses in asthma and that innate immune activation by allergens such as Alternaria may contribute to eosinophilic airway inflammation and mucus production.
Though asthma has many clinical, physiologic, and immunologic phenotypes, the majority of asthmatics have allergic triggers. Exposure to the fungal allergen A. alternata is specifically associated with severe asthma, including life-threatening exacerbations as well as thunderstorm-related asthma [7] [8] [9] [10] [11] [12] [13] . Thunderstorm asthma is a well-documented clinical phenomenon in which patients develop severe asthma symptoms in epidemics during a thunderstorm outflow when pollens and fungi are swept up and concentrated at high levels [14, 15] . This leads to an abundance of allergens, including the formation of respirable particles of pollen (<10 μm) and fragmented fungal spores of A. alternata [10] . IgE sensitization to grass pollen allergens, e.g. ryegrass, is a risk factor for patients to develop asthma exacerbations during thunderstorms suggesting a link between adaptive Th2 responses to grass pollen and thunderstorm asthma [16, 17] . Little is known about the underlying immune mechanisms in thunderstorm asthma beyond one report that demonstrated increased sputum eosinophilia and IL-5+ cells in the lungs of symptomatic asthmatics during thunderstorms suggesting a potentiated type 2 response [17] . The clinical associations between Alternaria , grass pollen exposure, and epidemics of severe asthma during thunderstorms are intriguing, but how these inhaled allergens might lead to increased airway inflammatory responses is unclear.
We hypothesized that an innate type 2 response induced by Alternaria extract may enhance eosinophilic lung inflammation induced by ryegrass pollen. We demonstrate that a single challenge with Alternaria extract enhances lung eosinophilia, peribronchial infiltration, and epithelial mucus production as well as Th2 cell and ILC2 recruitment in ryegrass-challenged wild-type mice. Our data suggest that the combination of innate and adaptive responses to allergens may contribute to severe asthma.
Materials and Methods

Mice
Female BALB/c mice (Jackson Laboratory, Bar Harbor, Me., USA) were used at 8-10 weeks of age. All animal experimental procedures were approved by the University of California San Diego Animal Subjects Committee.
Ryegrass and Alternaria Airway Inflammation Models
To induce airway inflammation with ryegrass pollen, mice were immunized intraperitoneally with 200 μg of ryegrass pollen extract ( Lolium perenne, lot 147138; Greer, Lenoir, N.C., USA) adsorbed to 2 mg of an aqueous solution of alum hydroxide (Aldrich) in 500 μl PBS or in PBS without alum on days 0 and 7. Intranasal ryegrass pollen (100 μg in 40 μl of PBS, LPS content 0.71 ng/ml by Lonza Limulus assay) was administered for 3 consecutive days under isoflurane anesthesia. Intranasal A. alternata extract (lot 177372; Greer) was given at a dose of 25 or 50 μg in 40 μl of PBS 3 days before or 3 days after ryegrass challenges. In some experiments, bronchoalveolar lavage (BAL) and lungs from mice were analyzed 3 days after Alternaria extract or PBS challenge. In other experiments, naïve mice were administered 100 μg of ryegrass extract intranasally daily for 3 days and euthanized 1 day later. Control challenges consisted of the same volume of PBS alone. All of the mice were euthanized 24 h after the final allergen challenge.
Lung Processing and BAL Cellular Analysis
BAL and lungs were processed as we have previously described [18] . Briefly, the BAL fluid was obtained by intratracheal insertion of a catheter and lavaged with 0.7 ml of PBS containing 2% filtered bovine serum albumin (Sigma). The BAL fluid was centrifuged at 1,500 rpm for 5 min and supernatants collected and frozen until ELISA was performed. Total BAL cells were counted with an Accuri C6 flow cytometer (BD). For lung processing, the lungs were fixed in 10% buffered formalin (EMS, Hatfield, Pa., USA) before being embedded in paraffin for subsequent sectioning and staining. In some experiments, lungs were placed in RPMI and single cell suspensions for FACS staining were obtained using a gentleMACS dissociator (Miltenyi) according to the manufacturer's protocol.
Flow Cytometry
BAL and lung cells were first incubated with a monoclonal antibody to CD16/CD32 (24G.2) for 10 min to block Fc receptors. BAL cells were stained with PE-conjugated Siglec-F, APC-conjugated Gr-1, and FITC-conjugated CD11c (eBioscience). BAL eosinophils were identified as Siglec F-positive, CD11c-negative cells as previously reported [19] . Neutrophils were identified as GR-1-positive, Siglec-F-negative cells. BAL Th2 cells were identified as T1/ST2-positive CD4+ cells after staining with biotin T1/ST2 (MD Biosciences) and CD4 (eBioscience) followed by streptavidin-APC (eBioscience). To identify lung and BAL ILC2, cells were stained with PerCP-conjugated CD45.2 (eBioscience) and lineage staining was performed only with FITC antibodies that included FITCconjugated lineage cocktail (Biolegend), CD11c (eBioscience), NK1.1 (eBioscience), CD4 (eBioscience), CD5 (BD Biosciences), CD8 (BD Bioscience), FcεR1 (Biolegend), TCRβ (BD Bioscience), TCRγδ (Biolegend), and CD19 (Biolegend). Lung cells were also stained with APC-conjugated Thy1.2 (eBioscience) and ILC2s were identified as lineage-negative, Thy1.2-positive lymphocytes as previously described [6, 20] . Ki-67 staining was performed using a FoxP3 staining kit (eBioscience) followed by APC-conjugated Ki-67 (eBioscience) [6, 20] . Flow cytometry was performed with an Accuri C6 cytometer (BD Biosciences) and sample data were further analyzed with FlowJo software (Tree Star).
BAL and Serum ELISA BAL supernatant IL-5 and IL-13 were measured by ELISA according to the manufacturer's instructions and read with a BioRad model 680 microplate reader. All ELISA kits used for BAL studies were from R&D Systems (Minneapolis, Minn., USA). For serum ryegrass-specific IgE, ELISA plates were coated with ryegrass extract (Greer) dissolved in PBS at a protein concentration of 10 μg/ ml. The plate was sealed and incubated overnight at 4 ° C followed by addition of serum samples. The plate was incubated overnight at 4 ° C and 2 μg/ml biotinylated anti-mouse IgE (Biolegend) was added followed by streptavidin-HRP (R&D) diluted 1: 200 and developed with TMB A and B (R&D).
Periodic Acid-Schiff Analysis
Paraffin-embedded lungs were sectioned at 5 μm onto microscope slides. Periodic acid-Schiff (PAS)-stained airway goblet cells were counted under a light microscope (×200 magnification). The numbers of PAS-positive as well as total epithelial cells were assessed in 6-10 medium-sized closed circular bronchi (defined by having approx. 100-150 luminal airway epithelial cells) starting with airways having the most mucus. At least 6-10 bronchioles were counted in each slide. Results are expressed as the ratio of PAS-positive cells/bronchiole calculated from the number of PAS-positive epithelial cells per bronchus divided by the total number of epithelial cells of each bronchiole. All slides were blinded during analysis and repeated by an independent observer.
Inflammation Index
Lung sections were stained with hematoxylin and eosin (HE). Peribronchial inflammation was scored as previously reported [18] . Briefly, inflammatory cell infiltrate around the bronchioles was assessed for severity (0, normal; 1, <3 cells thick in diameter; 2, 3-10 cells thick, and 3, >10 cells thick) and overall extent (0, normal; 1, <10% of sample; 2, 10-25%, and 3, >25%) in the visual field. The index was calculated by multiplying severity by extent, with a maximum possible score of 9.
Pulmonary Function Testing
In some experiments, invasive pulmonary function testing was performed using the flexiVent system (Scireq, Montreal, Que., Canada) and airway resistance analyzed by Scireq flexiVent 5.1 software as previously described [18] . Briefly, mice were anesthetized, cannulated via the trachea, administered increasing doses of methacholine, and airway resistance measured.
Statistical Analysis
Statistical analysis was performed using GraphPad Prism software. p < 0.05 was considered statistically significant.
Results
Development of a Ryegrass-Induced Lung Inflammation Model
To develop an eosinophilic lung inflammation model induced by ryegrass allergen, we sensitized mice via the intraperitoneal route twice with ryegrass with or without aluminum hydroxide (alum), a known Th2 adjuvant. Mice were subsequently challenged by intranasal administration of ryegrass for 3 days in a row ( fig. 1 a) . Control mice received intraperitoneal PBS injections and/or intranasal PBS instillations. Mice that were sensitized and challenged with ryegrass pollen developed significantly increased BAL airway total cell counts, eosinophilia, and neutrophilia compared with mice challenged with PBS ( fig. 1 b, c) . Interestingly, ryegrass-sensitized and -challenged mice developed an eosinophilic airway response even in the absence of the Th2 adjuvant alum, though not to the same extent ( fig. 1 c) . Mice receiving intranasal challenges with ryegrass without sensitization were found to have increased neutrophils in the BAL but a modest number of eosinophils, suggesting that sensitization was required before significant airway eosinophilia developed. BAL cytokines IL-5 and IL-13 were increased in mice sensitized and challenged with ryegrass compared with controls, but only IL-5 was further increased in the alum/ryegrass sensitization group ( fig. 1 d) . Thus, ryegrass sensitization with alum and subsequent challenges with intranasal ryegrass led to the largest increase in airway eosinophilia and IL-5 levels.
Two hallmarks of asthma are peribronchial inflammation and epithelial mucus production. We analyzed lung sections stained with HE to assess peribronchial infiltration as well as PAS to quantify mucus production from mice undergoing the protocol in figure 1 a. Lung sections from mice that were sensitized and challenged with ryegrass displayed increased peribronchial infiltration compared to control mice that were not sensitized ( fig. 2 a) . Consistent with the increased airway eosinophilia in figure 1 c, mice receiving alum with ryegrass during sensitization had a further increase in peribronchial inflammation scoring compared with ryegrass sensitization without alum. Lung sections analyzed for numbers of mucus-producing (PAS+) cells revealed that only ryegrass-sensitized mice developed epithelial mucus changes and alum administration with ryegrass greatly increased numbers of PAS+ epithelial cells ( fig. 2 b) . Thus, the protocol utilizing ryegrass sensitization with alum led to the most robust airway eosinophilia, BAL IL-5 levels, peribronchial infiltrate, and epithelial mucus production.
Importantly, sensitization to ryegrass prior to subsequent intranasal challenges was required for the development of airway eosinophilia and mucus production suggesting that this protocol models an adaptive Th2-driven response.
Alternaria Extract Induces ILC2 Proliferation and Recruitment of Eosinophils and Th2 Cells
We have previously demonstrated that a single challenge with Alternaria extract induces innate airway eosinophilia and type 2 innate lymphoid cell (ILC2) proliferation in naïve mice [5, 6] . We have defined the early type 2 response to Alternaria extract as innate because RAG2-deficient mice that lack B and T cells develop Alternaria extract-induced eosinophilia [6, 21, 22] . To confirm that ryegrass-sensitized, but not -challenged, mice also develop these features, we sensitized mice with ryegrass and alum and subsequently administered one challenged with Alternaria extract or PBS ( fig. 3 a) . Three days later, we analyzed BAL for levels of eosinophils and CD4+ T1/ST2+ cells ( fig. 3 b, c). T1/ST2 is the receptor for IL-33 and is preferentially expressed on murine Th2 cells compared with other CD4+ cells [23, 24] . As expected, BAL eosinophils after a single challenge with Alternaria extract were significantly increased compared with PBS in ryegrass-sensitized mice ( fig. 3 b) . Interestingly, we also found elevated airway Th2 cells (CD4+ T1/ST2+) in mice receiving 1 Alternaria extract challenge. We further measured the percentage of ILC2 of lung lymphocytes as well as ILC2 proliferation in these mice. ILC2 are CD45-positive, lineage-negative lymphocytes that do not express Mice received intraperitoneal injections of ryegrass with or without alum or PBS followed by either PBS or ryegrass intranasal challenges. PBS/ryegrass groups received intraperitoneal PBS followed by ryegrass challenges. BAL total cells ( b ) and eosinophil and neutrophil numbers ( c ) were counted 1 day after the last ryegrass challenge. d Levels of BAL IL-5 and IL-13; means ± SEM (n = 4-6 mice/group), * p < 0.05, * * p < 0.01 vs. the PBS/PBS group, unless otherwise shown, Mann-Whitney test.
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CD3, CD4, CD8, FcεR1, NK1.1, TCRαβ, TCRγδ, or CD19, but do express Thy1.2 [6, 20] . Alternaria extractchallenged mice displayed an increased percentage of lung lymphocytes that were ILC2 compared with PBSchallenged mice (2.6 vs. 1.7; fig. 3 d) . We have previously shown that lung ILC2 have increased proliferation 3 days after 1 challenge with Alternaria extract in naïve mice [6] . Consistent with these findings, we also found that the percentage of Ki-67 proliferating ILC2 in the lung were approximately double in Alternaria extract-versus PBSchallenged mice (39.7 vs. 19.8; fig. 3 e) . Thus, a single challenge with Alternaria extract induces innate airway eosinophilia, Th2 cell recruitment, and ILC2 proliferation in ryegrass-sensitized mice.
Prior to testing the hypothesis that an innate challenge with Alternaria extract may enhance lung inflammation induced by a conventional sensitization and challenge protocol with ryegrass ( fig. 1 ) , we considered the possibility that intranasal ryegrass extract in nonsensitized animals may also result in an innate type 2 lung inflammation. We therefore administered 3 daily doses of ryegrass to naïve mice and assessed levels of BAL eosinophils and neutrophils, and lung ILC2 proliferation. We detected a modest increase in BAL eosinophils and neutrophils after 3 rye grass challenges ( fig. 3 f) . Th2 cell recruitment was not different between groups (not shown). Further, there was no difference in the ILC2 percentage or proliferation in the lung between groups ( fig. 3 g, h) . Thus, innate challenges with ryegrass extract induce modest levels of airway inflammatory cell infiltration and no detectable ILC2 proliferation compared with Alternaria extract administration.
A Single Alternaria Extract Exposure prior to Ryegrass Challenges Enhances Lung Inflammation
We have previously shown that a single airway challenge with Alternaria extract given to unsensitized naïve mice leads to an influx of airway eosinophils, albeit to 97 levels far lower than an adaptive Th2 response after sensitization and repetitive challenges [5, 6] . As the findings in figure 3 demonstrate induction of innate eosinophilia and ILC2 proliferation after 1 challenge with Alternaria extract in ryegrass-sensitized but unchallenged mice, we next sought to identify a potential effect of a single Alternaria extract challenge given prior to ryegrass exposure. Mice were sensitized with ryegrass and alum ( fig. 1 , 2 ) and given 1 intranasal challenge with Alternaria 3 days prior to ryegrass challenges ( fig. 4 a) . Mice challenged with Alternaria extract and ryegrass developed significantly increased levels of BAL eosino- phils, neutrophils, and IL-13 compared to ryegrass-only challenges ( fig. 4 b-d) . In contrast, BAL IL-5 levels were not significantly increased above ryegrass-only challenges when mice received Alternaria extract prior to ryegrass challenges. We assessed stained lung sections from mice undergoing the protocol in figure 4 and found that mice receiving one challenge of Alternaria extract after sensitization with ryegrass and alum without further ryegrass intranasal challenges developed modest peribronchial inflammation and mucus production ( fig. 5 ). Sections from mice receiving ryegrass-only sensitization and challenges showed a further increase in airway infiltrate and mucus changes, though the combination of Alternaria extract and ryegrass challenges led to the largest and most significant increases. Thus, a single airway challenge with Alternaria extract given before ryegrass exposure enhances ryegrass-induced lung inflammation and mucus production.
Alternaria Extract Induces Airway Eosinophil, Th2
Cell, and ILC2 Recruitment To confirm that the effect of 1 challenge with Alternaria extract in figures 4 and 5 was not related to the specific Alternaria extract dose utilized (50 μg), we performed the protocol illustrated in figure 4 a with half of the dose of Alternaria extract (25 μg). Despite using a smaller dose of Alternaria extract, we detected an even greater relative increase in BAL total cells and eosinophilas ( fig. 6 a) in ryegrass-sensitized and -challenged mice receiving Alternaria extract. Levels of neutrophils were not significantly different. As we had detected increased Th2 cell recruitment after a single Alternaria extract challenge in ryegrass-sensitized mice ( fig. 3 c) , we further examined Th2 cell recruitment after both Alternaria extract and ryegrass administration in sensitized mice ( fig. 6 b) . We detected an additive effect of Alternaria extract and ryegrass on levels of airway Th2 cells in mice receiving challenges of both extracts. Levels of rye- grass-specific-serum IgE were elevated in all sensitized groups compared with unsensitized PBS-challenged mice ( fig. 6 c) , though the combination of ryegrass and Alternaria extract challenges did not increase specific IgE above ryegrass alone. However, there was a trend towards specific IgE increases in both ryegrass challenge groups compared with Alternaria extract only suggesting that airway ryegrass challenges (with or without Alternaria extract exposure) further increased serum-specific IgE in ryegrass-sensitized animals. Next, we determined whether ILC2 were recruited into the BAL in the different groups of mice. ILC2 have been shown to be absent in the BAL of unchallenged mice and are recruited after allergen challenge [25] . Interestingly, we found that the percentage of BAL lymphocytes that were ILC2 was threefold higher in Alternaria extract-challenged mice (with or without ryegrass challenges) compared to the ryegrassonly group ( fig. 6 d) . However, total numbers of BAL ILC2 were significantly higher in the ryegrass-challenged mice that received Alternaria extract. Thus, a single exposure of Alternaria extract in ryegrass-challenged mice induces recruitment of airway ILC2, eosinophils, and Th2 cells. Finally, we performed invasive airway hyperresponsiveness testing and determined that all three groups ( Alternaria , ryegrass, and Alternaria + ryegrass) showed increased airway resistance compared with naïve mice after administration of 24 mg/ml of methacholine, though the combination of Alternaria extract and ryegrass challenges showed the largest increase ( fig. 6 e) .
Alternaria Extract Exposure after Ryegrass Challenges Increases Airway Eosinophilia
We considered the timing of a single Alternaria extract challenge might influence the lung inflammation potenti- fig. 7 a) . Similar to Alternaria given before ryegrass challenges ( fig. 4-6 ), mice receiving Alternaria extract after ryegrass challenges had significantly increased BAL eosinophils compared with mice receiving only ryegrass challenges within the same respective protocol ( fig. 7 b, c) . Alternaria extract given alone to ryegrass-sensitized, but not challenged, mice the day before analysis revealed increased neutrophils and a modest number of eosinophils. The numbers of eosinophils in the BAL of mice receiving both Alternaria extract and ryegrass were synergistically increased when compared to the combined means of Alternaria extract-only and ryegrass-only groups. In contrast, BAL IL-5, IL-13, and neutrophils were increased, but not above Alternaria extract-only challenges ( fig. 7 d) . Further, when lung sections from these mice were analyzed for peribronchial infiltration and mucus production, sections from Alternaria extractand ryegrass-challenged mice displayed greater levels of Reduced-dose Alternaria extract increases airway eosinophil, Th2 cell, and ILC2 recruitment. Ryegrass-sensitized mice were administered either Alternaria extract (25 μg) or PBS followed by either ryegrass or PBS challenges 3 days later (n = 4 mice/group). a BAL total cells, eosinophils, and neutrophils were counted 1 day after the last challenge. * p < 0.05 vs. the ryegrass and Alternaria groups, t test. b BAL CD4+ T1/ST2+ cell counts, * p < 0.05 vs. the ryegrass and Alternaria groups, t test. c Serum ryegrass IgE levels. * * p < 0.01 vs. the PBS group, t test. d BAL ILC2 identified as CD45+ lymphocytes (top) and percent ILC2 from ryegrass, Alternaria , and ryegrass + Alternaria groups are shown (bottom). Total BAL ILC2 counts (top right, n = 4 mice/ group, BAL from 2 mice/group pooled for ILC2 staining). * p < 0.05 compared to the ryegrass group, t test. e Lung resistance after instillation of PBS followed by 3 and 24 mg/ml of methacholine (n = 3-4 mice/group).
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Int Arch Allergy Immunol 2014;163:92-105 DOI: 10.1159/000356341 101 inflammation and mucus production compared with ryegrass only ( fig. 8 ). The overall magnitude of peribronchial infiltrate was greater when Alternaria extract was given after compared to administration before ryegrass challenges. Taken together, Alternaria extract enhances BAL eosinophilia, airway inflammation, and mucus production in ryegrass-sensitized and -challenged mice. Importantly, Alternaria extract and ryegrass challenges induced a synergistic effect on BAL eosinophilia when Alternaria extract exposure occurred after ryegrass challenges.
Discussion
Our studies demonstrate that a single challenge with Alternaria extract given 3 days before or 3 days after ryegrass challenges results in increased airway eosinophils, IL-5, and IL-13 levels as well as peribronchial inflammation and mucus production compared with ryegrass-only challenges. Further, a single Alternaria extract given to ryegrass-sensitized, but unchallenged, mice induced airway eosinophilia, Th2 cell recruitment, as well as ILC2 expansion and proliferation. Additionally, unsensitized mice receiving 3 days of ryegrass only developed modest airway eosinophilia and neutrophilia. Finally, we determined that Alternaria extract enhanced recruitment of airway eosinophils, Th2 cells, and ILC2 in ryegrass-challenged mice despite not having an effect on serum ryespecific IgE.
Importantly, this is the first study to our knowledge to investigate the effect of an innate type 2 response to an allergen given during a conventional recall lung inflammatory response to another allergen. Innate type 2 responses to allergens have only recently been recognized as possibly contributing to lung inflammatory responses. Studies in mice have demonstrated that allergens can induce eosinophilic lung inflammation, Th2 cytokine production, and mucus metaplasia in the absence of B and T cells [6, 21, 26, 27] . The first report showed that a single administration of purified fungal allergen protease from Aspergillus given to RAG1-deficient mice led to lung eosinophilia within 18 h [27] . Since then, our group and others have reported that a single airway challenge with Alternaria extract induces an innate type 2 response in mice that is not dependent on adaptive immunity [5, 6, 21, 22] . Further work has identified type 2 innate lymphoid cells (ILC2) as major producers of IL-5 and IL-13 in allergen challenge models, including Alternaria extract, papain protease, house dust mite, and ovalbumin models [21, 25, 26, 28] . Our current studies also show that ILC2 proliferate after Alternaria extract challenge in ryegrass-sensitized mice and are recruited to the BAL in larger numbers in ryegrass-challenged mice. Though the relative contribution of Th2 cytokine production by ILC2 compared to other cells, including Th2 cells, in our models is unclear, it is conceivable that human asthmatics may have both innate and adaptive Th2 inflammatory responses after allergen inhalation that result in asthma flares. We chose to develop a model utilizing ryegrass and Alternaria extracts as allergens based on reports of severe asthma symptoms associated with these allergens during thunderstorms [10, 16, 17] . Though IgE sensitization to these allergens was found to be a risk factor for having asthma exacerbations during thunderstorms, the mechanism leading to asthma symptoms is not clear, as has been discussed elsewhere [14, 15] . The suggestion that an innate response to Alternaria extract in ryegrass-sensitized Color version available online and -challenged mice translates to a mechanism of human thunderstorm asthma is speculative. We have not adequately studied the effect of thunderstorms in allergen-challenged animal models or controlled for fungal spore allergens that humans inhale compared with the extracts that we have administered to mice. Further, though doses of allergens used in mouse models are magnitudes higher per weight than humans inhale, insights into potential immune mechanisms may still be gained. Additionally, we chose to study different time points of allergen challenge and endpoint analysis in order to more broadly study the lung response to Alternaria extract under different conditions, and thus direct comparison of results from different protocols may not be possible. Despite these caveats, the timing of symptoms in thunderstorm-related asthma appears to be very rapid in pollenallergic patients and correlates with the release of allergen particles, including Alternaria , raising the possibility that rapid innate responses could occur in addition to IgEmediated or other mechanisms [14] .
In the current studies, we have detected modestly elevated eosinophils, neutrophils, and Th2 cytokines in the BAL of unsensitized mice receiving ryegrass over 3 days. Recently, ryegrass has been shown to contain immunostimulatory properties, including TLR ligands and β-1,3-glucans [29] . Further, in vitro studies have previously shown that ryegrass induced detachment of mouse airway epithelial cells in a protease-dependent manner [30] . These reports suggest that ryegrass extract has proinflammatory properties that could contribute to an innate type 2 response in addition to that of Alternaria extract in our models. Though we detected a small increase in Th2 cytokines and eosinophils after ryegrass exposure in unsensitized mice, we did not detect a change in percent ILC2 or proliferation compared with that induced by Alternaria . The possibility exists that the innate response to ryegrass is not ILC2 mediated or that ILC2 cytokine production is induced without a significant effect on proliferation at the time point we measured.
In our studies, we found that a single challenge with Alternaria extract given to ryegrass-challenged mice exacerbated the degree of eosinophilic lung inflammation despite not having a further influence on ryegrass-specific IgE levels. There are several possible mechanisms that may have contributed to these findings. First, our data support an increased Th2 cell recruitment to the airways after Alternaria extract exposure and prior to ryegrass challenges. An increased Th2 cell number could more robustly respond to ryegrass antigen resulting in greater IL-5 and IL-13 production and locally increased eosinophilia and mucus production without a significant effect on serum-specific IgE production. Second, we have shown that ILC2 proliferate after Alternaria extract exposure and the greater numbers of ILC2 could produce more Th2 cytokines upon exposure to ryegrass in the lung without influence on ryegrass IgE. Finally, other cell types, including mast cells, basophils, natural killer T cells, and eosinophils, could be induced by Alternaria extract challenge to increase Th2 cytokine production as well as airway epithelial cell chemokine secretion. Though significant complexity likely exists in our model systems, the possibility that a type 2 response in the lung can be enhanced without a significant effect on systemic allergen-specific IgE levels is an interesting subject for further investigation and may help to elucidate eosinophilic asthma that is discordant with the IgE status [31] .
Alternaria extract administered after ryegrass challenges led to a more significant increase in the number of BAL eosinophils and a greater degree of lung inflammation compared with Alternaria given before ryegrass. One possibility for this difference may be that eosinophils recruited into the lung by ryegrass challenges become directly activated by subsequent Alternaria extract challenge leading to increased inflammation and eosinophilia. Consistent with this, one report demonstrated that Alternaria extract can directly induce innate activation and degranulation of human eosinophils [32] . As the timing of allergen exposure is likely important in the response seen, we chose to administer Alternaria extract before and after ryegrass to be able to assess differences in the type 2 responses in the lungs. We did perform experiments with co-administration of Alternaria extract and ryegrass on the same days (not shown), but due to the early additive neutrophilic effect of concomitant ryegrass and Alternaria exposure, it was difficult to identify a significant eosinophilic component at the time points we measured. The Alternaria and ryegrass allergen extracts we utilized are crude complex extracts that likely have the ability to activate many pattern recognition receptors, leading to mixed responses, including early neutrophilia. Importantly, one study demonstrated that patients with asthma symptoms during thunderstorms developed increased sputum eosinophilia and IL-5+ cells indicative of a type 2 response that is more consistent with the response we detected using the protocols shown in figures 4 and 7 [17] . Thus, the timing and kinetics of innate and adaptive type 2 responses to allergens may be critical to the type of inflammatory responses that occur in the airways.
Finally, we detected increased mucus production in mice that received one challenge with Alternaria extract in addition to ryegrass challenges. This result was more robust when Alternaria extract was given prior to ryegrass challenges and may be due to sufficient time for mucus accumulation to occur between Alternaria extract challenge and lung sample collection. We also detected an increase in IL-13 levels in the airways in these mice, and the relationship between IL-13 and mucus production is strongly supported in the literature [33] [34] [35] . Severe asthma symptoms in humans, including fatal asthma, have been associated with increased airway mucus exudate and could be partially responsible for Alternaria-and ryegrass-induced symptoms [36] .
In summary, we found that a single challenge with Alternaria extract enhances lung eosinophilia, peribronchial infiltration, and mucus production induced by ryegrass challenge. Our data suggest that the combination of innate and adaptive responses to allergens may contribute to severe asthma. Further work to identify mediators of both innate and adaptive responses may lead to the identification of predictive biomarkers or therapeutic targets for patients with severe asthma symptoms triggered by allergens.
